Skyepharma’s mission and strategy

Our mission

Skyepharma’s mission is to apply its proven scientific expertise and proprietary drug delivery technologies to develop oral and inhalation pharmaceutical products which provide benefits to patients, meet market needs and create value for stakeholders.

Our business strategy

Skyepharma’s business strategy is to apply its proven scientific expertise and proprietary drug delivery technologies to develop oral and inhalation pharmaceutical products which provide benefits to patients, meet market needs and create value for stakeholders. Whilst continuing to benefit from revenues from existing approved products, Skyepharma aims to enhance its product pipeline by identifying additional innovative products through its own research as well as through collaborations with partners. Revenues are generated from licensing and milestones, product supply and contract development work.

Drug delivery and inhalation products developed by Skyepharma

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.